Cover Image
Market Research Report
Product code
711729

Global Electroporation Instruments Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Electroporation Instruments Market 2021-2025
Published: May 26, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Technavio has been monitoring the electroporation instruments market and it is poised to grow by $ 87.59 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Our report on electroporation instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising demand for monoclonal antibodies and emerging economies offering growth opportunities. In addition, rising demand for monoclonal antibodies is anticipated to boost the growth of the market as well.

The electroporation instruments market analysis include end-user segments and geographic landscape.

Technavio's electroporation instruments market is segmented as below:

By End-user

  • Pharma and biotech companies
  • Academic and research institutes
  • CROs

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing incidence and prevalence of cancer as one of the prime reasons driving the electroporation instruments market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on electroporation instruments market covers the following areas:

  • Electroporation instruments market sizing
  • Electroporation instruments market forecast
  • Electroporation instruments market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroporation instruments market vendors that include BEX Co. Ltd., Bio Rad Laboratories, Inc, Celetrix LLC, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC., and Thermo Fisher Scientific Inc. Also, the electroporation instruments market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents
Product Code: IRTNTR40621

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by End-user
    • Market segments
    • Comparison by End-user
    • Pharma and biotech companies - Market size and forecast 2020-2025
    • Academic and research institutes - Market size and forecast 2020-2025
    • CROs - Market size and forecast 2020-2025
    • Market opportunity by End-user
  • Customer landscape
    • Overview
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
    • Competitive scenario
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • BEX Co. Ltd.
    • Celetrix LLC
    • Eppendorf AG
    • Harvard Bioscience Inc.
    • Lonza Group Ltd.
    • MaxCyte Inc.
    • Merck KGaA
    • Mirus Bio LLC.
    • Thermo Fisher Scientific Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: End user - Market share 2020-2025 (%)
  • 22: Comparison by End user
  • 23: Pharma and biotech companies - Market size and forecast 2020-2025 ($ million)
  • 24: Pharma and biotech companies - Year-over-year growth 2020-2025 (%)
  • 25: Academic and research institutes - Market size and forecast 2020-2025 ($ million)
  • 26: Academic and research institutes - Year-over-year growth 2020-2025 (%)
  • 27: CROs - Market size and forecast 2020-2025 ($ million)
  • 28: CROs - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: BEX Co. Ltd. - Overview
  • 50: BEX Co. Ltd. - Product and service
  • 51: BEX Co. Ltd. - Key offerings
  • 52: BEX Co. Ltd. - Key customers
  • 53: BEX Co. Ltd. - Segment focus
  • 54: Bio Rad Laboratories, Inc - Overview
  • 55: Bio Rad Laboratories, Inc - Business segments
  • 56: Bio Rad Laboratories, Inc - Key offerings
  • 57: Bio Rad Laboratories, Inc - Key customers
  • 58: Bio Rad Laboratories, Inc - Segment focus
  • 59: Celetrix LLC - Overview
  • 60: Celetrix LLC - Product and service
  • 61: Celetrix LLC - Key offerings
  • 62: Celetrix LLC - Key customers
  • 63: Celetrix LLC - Segment focus
  • 64: Eppendorf AG - Overview
  • 65: Eppendorf AG - Business segments
  • 66: Eppendorf AG - Key offerings
  • 67: Eppendorf AG - Key customers
  • 68: Eppendorf AG - Segment focus
  • 69: Harvard Bioscience Inc. - Overview
  • 70: Harvard Bioscience Inc. - Business segments
  • 71: Harvard Bioscience Inc. - Key offerings
  • 72: Harvard Bioscience Inc. - Key customers
  • 73: Harvard Bioscience Inc. - Segment focus
  • 74: Lonza Group Ltd. - Overview
  • 75: Lonza Group Ltd. - Business segments
  • 76: Lonza Group Ltd. - Key offerings
  • 77: Lonza Group Ltd. - Key customers
  • 78: Lonza Group Ltd. - Segment focus
  • 79: MaxCyte Inc. - Overview
  • 80: MaxCyte Inc. - Business segments
  • 81: MaxCyte Inc. - Key offerings
  • 82: MaxCyte Inc. - Key customers
  • 83: MaxCyte Inc. - Segment focus
  • 84: Merck KGaA - Overview
  • 85: Merck KGaA - Business segments
  • 86: Merck KGaA - Key offerings
  • 87: Merck KGaA - Key customers
  • 88: Merck KGaA - Segment focus
  • 89: Mirus Bio LLC. - Overview
  • 90: Mirus Bio LLC. - Product and service
  • 91: Mirus Bio LLC. - Key offerings
  • 92: Mirus Bio LLC. - Key customers
  • 93: Mirus Bio LLC. - Segment focus
  • 94: Thermo Fisher Scientific Inc. - Overview
  • 95: Thermo Fisher Scientific Inc. - Business segments
  • 96: Thermo Fisher Scientific Inc. - Key offerings
  • 97: Thermo Fisher Scientific Inc. - Key customers
  • 98: Thermo Fisher Scientific Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations